Available via license: CC BY 4.0
Content may be subject to copyright.
International Journal of Scientific Research and Management (IJSRM)
||Volume||11||Issue||02||Pages||MP-2023-822-827||2023||
Website: www.ijsrm.in ISSN (e): 2321-3418
DOI: 10.18535/ijsrm/v11i02.mp01
Dr. Chr. Damyanov, IJSRM Volume 11 Issue 02 February 2023 [www.ijsrm.in] MP-2023-822
Clinical Experience of the Application of Intravenous Therapy with
VIT. C, Ozonotherapy and Biomagnetic Therapy
Dr. Chr. Damyanov*, MD, PhD., Dr. Vl. Pavlov, Dr. Al. Todorov, Iv. Pashina
Medical Center "Integrative Medicine", Sofia, Bulgaria
Abstract:
On the background of the announced COVID-19 pandemic, the treatment of seasonal viral infections
demonstrates a serious irrational approach by ignoring numerous scientific publications about methods
from the arsenal of integrative medicine. Among these methods stand out: intravenous vitamin C
application in high doses, Ozone therapy and Scalar Biomagnetic therapy (SBT) with magnetic pairs. After
a thorough review of a number of scientific publications and based on our clinical experience of the
application of these methods in oncological diseases, we have prepared our own protocol for the treatment
of viral diseases including these three methods. The protocol was prepared in January 2021. In this
publication, we present the first results using this method for the treatment of oncological and viral diseases.
Key Words: Viral epidemics, Coronavirus, Cancer, Insulin Potentiation Therapy, Ozonotherapy, high doses
vit. C, Scalar Biomagnetic Therapy
Introduction:
Diseases of the upper respiratory tract are common seasonal manifestations of a variety of viral infections.
Among the most common viral infections are rhinoviruses affecting 30% of adults with multiple antigenic
variations, parainfluenza or respiratory syncytial viruses, adenoviruses, enteroviruses, influenza (A, B, C), as
well as coronaviruses (1).
Currently, the treatment of seasonal viral infections is symptomatic predominantly with pharmacological
preparations, and the only hope of prevention for their spread is quarantine with masks and immunization (2,
3,4).
On the background of the declared COVID-19 pandemic, for one or another reason, facts and information
from numerous scientific publications are being ignored that there are serious possibilities for treatment, and
it is successfully applied by physicians engaged in the application of methods from the integrative medicine
arsenal. Among the used methods are: Intravenously administered vitamin C in high doses, Ozone therapy
and Biomagnetic Therapy (BT) with magnetic pairs (5,6).
After a thorough review of numerous scientific publications, we focused mainly on three methods: intravenous
administration of high doses of vitamin C, Ozone therapy, and BT with magnetic pairs. BT was modified by
using scalar devices (SBT). Based on our clinical experience of the application of these methods in oncological
diseases and the literature review, we have prepared our own protocol for the treatment of viral diseases that
includes these three methods. The protocol was prepared in January 2021.(7,8)
Description;
In this publication, we present the first results using this method for the treatment of oncological and viral
diseases,
The main goal of the study is to evaluate the efficacy and safety of the application of the protocol we created
for oncological patients, with or without viral infections.
The study includes patients with oncological diseases and those without oncological diseases who entered the
clinic for treatment between January 2021 and January 2022.
On admission to the clinic, we take the patient's history of symptoms of viral infections, as well as for contact
with other persons with viral diseases.
Dr. Chr. Damyanov, IJSRM Volume 11 Issue 02 February 2023 [www.ijsrm.in] MP-2023-823
The diagnosis is based on clinical examination, laboratory tests, image tests, Beretta symptom index,
Autonomic muscle test (5), oximetry, AMP Rapid Test SARS-CoV-2 IgG/IgM and Influenza A+B.
Treatment includes daily procedures with SBT combined sequentially with intravenously administered Vit.C
– 12.0g + ALA (600 mg) on the first day. On the next day the Biomagnetic therapy is combined with
intravenous Ozone therapy. Procedures are alternated at an interval of 6-7 days in mild and asymptomatic
cases, and 10-12 days in impaired patients.
After the treatment, control tests are carried out, which include: laboratory tests, imaging if necessary, Beretta
symptom index test, neuromodulation test, oximetry, AMP Rapid Test SARS-CoV-2 IgG/IgM and Influenza
A+B.
Method of Carrying Out With Vit.C Infusion:
Intravenously administered Vit. C (12 g) + ALA (Thiogamma 600 mg.). The procedures take place every
other day. Total number of procedures is from three to six.
Method Of Carrying Out Intravenous Ozonotherapy:
Ozone therapy is carried out by the method of intravenous administration of an ozonated 250 ml 0.9% NaCl.
A "Medozons BM" device was used to generate ozone. The density of infused ozone is 3200 µg/L. Duration
of the procedure – 35 min. These procedure take turns winh Vit. C in hibh doses and the total number is from
three to six.
Methodology For BT:
After a long research period, we included BT with magnetic pairs in 2016 for the treatment of oncological
diseases, initially using the application of static magnets. (9)
Fig.1: Biomagnetic therapy with static magnets.
After 2018 we introduced the SBT which significantly expanded our therapeutic possibilities and the arsenal
of the methods used by us. .The SWD SWA-A device created by Prof. Konstantin Meyl for energy and
information transfer was used for the procedure. Biomagnetic programs for the treatment of oncological,
infectious and other chronic diseases, as well as programs for stimulating the body's immune system, are
recorded on computer discs (CD). The electronic version of Rodriguez's Biomagnetism book (v. 12.3) was
used to create these biomagnetic programs, as well as the Biomagnetism Guide by Dr. David Goiz Martinez
and the Biomagnetic Guide (BMG v 4.1; 5.1 and 6.1) (9, 10).
Fig.2 Device SWD SWA-A created by Prof. Konstantin Meyl for energy and information transfer.
Dr. Chr. Damyanov, IJSRM Volume 11 Issue 02 February 2023 [www.ijsrm.in] MP-2023-824
The procedure is to place two CDs with recorded Biomagnetic programs on the receiver of the scalar device.
Disc 1 includes magnetic pairs for tumor diseases, viral infections, detoxification, immune stimulation and
emotional disbalance. Disc 2 includes programs for concomitant chronic diseases.
A glass bottle of water is placed on the transmitter for homeopathic information transfer. The patient drinks
the water after the procedure. It lasts 30 minutes.
After the procedure, a control Autonomic muscle test is performed to measure the effectiveness of the
treatment. In case the test shows the presence of unbalanced magnetic pairs, the procedure is repeated (10,
11).
Results:
For the period January 2021 - January 2022 we treated 69 patients as a total. 50 of them (72,4 %) were
oncological patients and they all had latent or manifest viral infection and another nine (13 %) with viral
infections without oncological diseases. Eight 8 (16%) of the treated oncological patients in the clinic are in
stage I and II. Fourty two 42 (84%) patients are in stage III and IV. Thirty-six 36 (85.7%) of these advanced
(III and IV) stage disease patients are only suitable for palliative treatment.
Oncological patients with COVID-19 were just 10 (20%) patients one (1) patient is with asymptomatic
infection, 4 with mild infection, 3 with moderately severe infection and 2 with severe infection.
The remaining 40 (80 %)had other viral diseases: flu (Influenza), adenoviruses, enteroviruses. Fourteen 14
(35%) of them were with asymptomatic infection, 18 (45%) with a mild infection, 6 (15%) with moderate
infection, and 2 (5%) with severe infection.
There were 9 patients with viral infections without oncological diseases. One (1) patient is with asymptomatic
infection, 2 with mild infection, 2 with moderately severe infection and 4 with severe infection (Table 1).
Table 1. Clinical characteristics of the patients
Two patients have positive testes for COVID-19. Before the treatment, three of the patients were vaccinated
against COVID-19 of their own volition. One of the vaccinated patients has COVID-19, and the rest have the
flu.
The symptomatology of patients with COVID-19 and those with other viral infections does not show
significant differences.
SEVEREtY PATIENTS
ONCOLOGICAL PATIENTS
WITH COVID-19
NUMBER/PERCENT
10 (20 %)
ASYMPTOMATIC INFECTION
1
MILD INFECTION
4
MODERATE INFECTION
3
SEVERE INFECTION
2
PATIENTS IN STAGE I AND II
PATIENTS IN STAGE IIIAND IV
N/A
8 (16 %)
42 (84 %)
ONCOLOGICAL PATIENTS
WITH OTHER VIRUSES
NON ONCOLOGICAL PATIENTS
40 (80 %)
9
2 (5 %)
4
14 (45 %)
1
18 (36 %)
2
6 (15 %)
2
N/A
Dr. Chr. Damyanov, IJSRM Volume 11 Issue 02 February 2023 [www.ijsrm.in] MP-2023-825
Two of the admitted patients with oncological diseases and viral infections had a previous vaccination for
COVID-19. One of them entered the clinic in a severely impaired state and progressive liver failure. This
necessitated an emergency referral to an intensive care unit. The other vaccinated patient responded
successfully to the treatment.
A third vaccinated patient, in the course of his cancer treatment, voluntarily administered a booster dose
without notifying us. This led to serious side effects and required discontinuation of the treatment of the
underlying disease. The patient was referred to recovery treatment to manage the serious side effects. (third
case)
The duration of therapy for patients with mild and moderately severe infections is 6-7 days. Only in two
patients with severe infections the treatment lasted 10-12 days. Control tests demonstrated a significant
improvement in all patients except one, who arrived after vaccination in an extremely damaged state, and
required resuscitation care.
The achieved results allowed the treatment of the oncological disease to continue according to a prepared
individual program. In the course of the treatment, no significant side effects and complications requiring
hospital treatment were registered. During the preventive examinations of the staff of the clinic, viral
infections were detected twice in 6 of the staff members, 3 of them were asymptomatic and the rest with mild
symptoms. The performed diagnostic tests showed no infection with COVID-19. Each of them successfully
underwent SBT which did not require additional treatment or interruption of their work activities.
Cases From Practice:
First case:
A 69-year-old man L.A.A. with complaints for 10 days - dry cough, shortness of breath, pronounced adynamia,
elevated temperature up to 39ᵒС, loss of appetite and chest pains. The patient is cancer-free. He was admitted
for diagnostic clarification and treatment on March 10, 2021. Auscultation in the right lung base - presence of
moist rales. SpO2 – 85 %. From laboratory tests – hypoalbuminemia, increased total and direct bilirubin, as
well as an increase in all liver tests, presence of protein and urobilinogen in urine, Abbott Diagn. SARS-Cov
2 (IgG) – 36275.90 AU/ml. Reference: < 50 (-) negative; > 50 (+). Rö gr pulmo et cor - the middle and lower
lung fields with bilateral pneumonia. High standing of the right diaphragmatic dome - effusion, probably also
with reaction of the interlobar pleura.
We performed the treatment with high doses of vit. C, intravenous ozone therapy and SBT. During the
treatment which lasted eight days the general condition improved significantly, the pain and cough
disappeared, the body temperature dropped to normal, the appetite was restored, and the laboratory parameters
were normalized. Follow-up imaging studies demonstrated complete response to the treatment.
Second case:
A 64-year-old patient Z.M.G. with advanced left breast carcinoma was successfully treated in the clinic in
February 2018 with IPT&BMT, and in remission for 3 months. She was then lost to follow up. This female
patient was admitted again for treatment on 03/24/2021 with evidence of a relapse of the disease, combined
with pronounced symptoms of a viral disease - temperature, chills, dry cough, pain, tightness in the chest and
pronounced adynamia.The patient was positive for COVID-19 IgG antibodies - Abbott Diagn. SARS-COV-2
IgG II – 4746.30 (< 50) negative; (> 50) positive. Rö gr pulmo et cor - well expressed peribronchitic changes.
The patient was treated with high doses of vit. C, intravenous Ozone therapy and SBT. Within ten days, the
objective status progressively improved – the cough, fever and pain disappeared, and the general condition
improved significantly. This made it possible to continue the treatment of the main disease - scalar insulin
potentiation therapy, Ozone therapy and SBT. We performed 10 treatment procedures. The performed control
tests reported disease remission with full recovery of working capacity. Three months after treatment, the
patient was again lost to follow-up.
Third case:
A 56-year-old patient K.D.R. was diagnosed in September 2020 with anorectal carcinoma without metastases.
The patient was treated with 35 days of radiation therapy combined with oral chemotherapy. During follow-
up fibrocolonoscopy (FCS) and PET/CT after the operation, a residual tumor formation with slightly reduced
sizes and pronounced inflammatory changes in the absence of metastases was detected. He was admitted to
the clinic for treatment on 09/27/2021 with no symptoms of a viral infection and was negative for COVID-
Dr. Chr. Damyanov, IJSRM Volume 11 Issue 02 February 2023 [www.ijsrm.in] MP-2023-826
19. She was put on combined IPT&BMT therapy after high dose Vit C therapy, intravenous Ozone therapy
and SBT. Subsequently, six IPT applications were conducted. At the end of November, the patient's condition
suddenly worsened. A nasopharyngeal infection and the presence of the influenza virus were detected. At the
same time, the patient informed us that she had previously been treated with two doses of vaccines for COVID-
19 without notifying us. The acute worsening of the condition occurred after the third booster dose. Subsequent
clinical and laboratory tests showed a pronounced inflammatory reaction and intoxication. IPT treatment had
to be stopped, and we started a recovery therapy with Ozone, high doses of vit, C and SBT. After two weeks,
the follow-up examinations and tests showed that despite resolution of symptoms, intravenous IPT could not
be resumed. The patient was offered scalar IPT&BMP, which she refused. The presented case is another
example from our clinical practice of serious consequences of the administration of vaccines in the treatment
of patients with oncological diseases.
Inferences:
Our clinical experience accumulated so far in the treatment of patients with oncological diseases allowed us
to draw the following conclusions:
The fact that latent or manifest viral infection was found in all oncology patients admitted to the clinic
is mainly explained by the seasonal activity of viral diseases, side effects of previous conventional
treatment, concomitant chronic diseases and increased stress. All this has implications for immune
deficiency.
In all oncological diseases with viral infections, a pronounced inflammatory reaction was found,
which, against the background of reduced immunity, is the reason for the activation of the disease.
The used diagnostic tests for COVID-19 are of questionable information value, and cannot be decisive
in the diagnostic and treatment process.
Due to the created fear psychosis among the population during the pandemic, the number of treated
patients in the clinic was significantly reduced (by more than 40%). We were put in a situation to
predominantly treat patients with indications for palliative treatment, which affects the efficacy of the
treatment we administer. The created stressful situation seriously worsens their condition, and has
serious consequences, especially in advanced cases. Discontinuation of the treatment of patients with
oncological diseases was massively observed in the same period in other medical institutions in our
country.
The protocol prepared and implemented by us for the treatment of viral diseases demonstrates a high
therapeutic effectiveness even in cases bordering on palliative care. In practice the treatment is without
any side effects. Moreover, accumulated clinical experience demonstrates that this protocol can also
be successfully applied to the treatment of oncological diseases.
Our practical activity in the treatment of viral diseases has shown that without special suits and masks
of the staff with strict observance of standard hygiene requirements, the safety of the staff can be
ensured without any problems.
Based on serious scientific facts and data, as well as on our own clinical experience, the treatment of
cancer patients with antiviral vaccines is extremely undesirable and carries a serious risk for disease
progression.
Conclusions:
The presented results of the application of our protocol of combined treatment with high doses of intravenously
administered vit. C, Ozone therapy and SBT show that this technique can be successfully applied to viral
infections without any side effects. The protocol prepared by us for the treatment of viral diseases became
necessary as a mandatory preparatory treatment for patients with oncological diseases.Our accumulated
experience so far gives us reason to consider untenable the imposed paradigm that incurable viral diseases are
affected only by antiviral vaccines.The observations in our country in the course of the pandemic demonstrated
another worrying fact - the stress and the created psychosis not only had negative consequences on the immune
system of the population, but also led to interruption and mass refusal of treatment for oncological patients
with all the consequences of this.An urgent reassessment of the consequences of the treatment activities carried
Dr. Chr. Damyanov, IJSRM Volume 11 Issue 02 February 2023 [www.ijsrm.in] MP-2023-827
out during the pandemic is imperative, as well as the development of new treatment strategies and actions
based solely on scientific facts and data.
References;
1. Sheldon L. Spector, MD The common cold: Current therapy and natural history J Allergy Clin
Immunol. 1995 May; 95(5): 1133–1138.Published online 2005 Nov 30. doi: 10.1016/S0091-
6749(95)70218- 0PMCID: PMC7112258
2. Dennis Wat* PMID: 7751530 The common cold: Current therapy and natural history Review article
The common cold: a review of the literature., European Journal of Internal Medicine 15 (2004) 79 –
88
3. Therapeutics and COVID-19: living guideline 14 July 2022 COVID-19: Clinical care -
https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2022.4
4. Charan Thej Reddy Vegivinti, Kirk W. Evanson, Hannah Lyons, Izzet Akosman, Averi Barrett, Nicole
Hardy, Bernadette Kane, Praneeth Reddy Keesari, Yashwitha Sai Pulakurthi, Erin Sheffels, Prasanth
Balasubramanian, Richa Chibbar, Spandana Chittajallu, Kathryn Cowie, J. Karon, Lauren Siegel,
Ranita Tarchand, Caleb Zinn, Nitin Gupta, Kevin M. Kallmes, Kavitha Saravu & Jillienne Touchette;
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials;
BMC Infectious Diseases, volume 22, Article number 107, Published: 31 January 2022
5. Christo Damyanov, MD, PhD, Aleksandar Todorov MD and Vladimir Pavlov MD It’s Time to
Change the Concept of Cancer Treatment. Some New Perspectives International Journal of Recent
Advances in Multidisciplinary Research Vol. 08, Issue 06, pp. 6997-7001, June, 2021
6. Christo Damyanov*, Ivan Maslev, Vladimir Pavlov, Aleksandar Todorov Coronavirus Is It Curable?
International journal of science and research methodology June 2020 Vol.:15, Issue:4: 1-13.
7. Chr. Damyanov*MD, Vl. Pavlov MD, Iv. Maslev MD, Personalized Treatment Application in
Integrative Oncology, Paripex, Volume 7, Issue 1, January 2018,
8. Damyanov C MD, PhD , Maslev I MD, Pavlov V MD and Todorov A MD A New Treatment Method
of Advanced Metastatic Tumors Annals of Clinical Case Reports, Case Series, Published on 11 April
2019.
9. Mario Ricardo Rodriguez Ramirez. Book of Biomagnetic Pairs. Jalisco: Chilife Virtual University;
2019.
10. David Goiz Martinez Biomagnetic Pair Guide 2. Ed. BRI Biomagnetism Research Institute. 2017.
Book 148 pages.
11. BMG Biomagnetic Guide 6.1 https://biomagneticguide.com/.
